CD44 and neoplasm: Single-cell RNA-seq confirmed CD44 expression in both tumour and immune cells, linking it to a protumor immune microenvironment.<h4>Conclusions</h4>CD44 is a promising early biomarker of hepatocarcinogenesis and a potential therapeutic target.